Feeling Better Again - Coping with Chemotherapy
This video covers topics such as:
Cellular Vaccine Development as Cancer Therapy
What are cellular vaccines and how do they differ from what we think of as conventional vaccines? What are the various types of approaches that we can potentially use for inducing anti-cancer immunity? Dr. Don Siegel, vice chair and professor of pathology and laboratory medicine at Penn Medicine, talks with host Dr. Lee Freedman about the exciting potential of cellular vaccines as cancer therapy.
STAND UP TO CANCER SHOW
On Friday night, Sept. 5th, over 50 of the most renowned personalities in TV, film, sports and music came together to make history. In an unprecedented television event, NBC, ABC, and CBS simultaneously devoted 1 hour of commercial-free prime time to raise funds for the fight against cancer. Craig Thompson, MD, Director, Abramson Cancer Center was selected to be part of the SU2C "Dream Team" of scientists to conduct collaborative research in pancreatic cancer treatment. As a participant in the SU2C effort, the Abramson Cancer Center is proud to provide patients, caregivers and researchers with the opportunity to watcht the entire hour of television that launched this phenomal effort to fight cancer and find a cure.
Celebrating Innovations 2008: Abramson Cancer Center Research Report and Annual Reception
The Research Report, “Clinical Integration Across Disciplines – Cancer Prevention, Diagnosis, and Cure in Philadelphia” featured the leadership of the Abramson Cancer Center speaking on the clinical integration efforts across disciplines to advance cancer prevention, diagnosis and cure. The three specialty areas highlighted were breast cancer, melanoma, and lung cancer.
Defining Benign vs. Malignant Palpable Masses
When a patient presents with a palpable mass, how can we ensure a proper diagnosis? Is pain often a false gauge of severity? Host Dr. Lee Freedman speaks with Dr. Richard Lackman, professor and chair of orthopaedic surgery and director of the Sarcoma Center of Excellence at the Abramson Cancer Center within the University of Pennsylvania Health System, about treatment modalities for a variety of palpable masses. When should patients be referred to a specialist?
Implementing Proton Therapy for Cancer Treatment
Dr. Stephen Hahn, professor and chair of radiation oncology at the University of Pennsylvania School of Medicine, details advances in our understanding of proton therapy. This innovative cancer treatment could be of great benefit to patients, but, Dr. Hahn cautions, we're still in the early stages of development. Current research must be conducted with the utmost precision. Find out more with host Dr. Lee Freedman.
Molecular Biology and Personalized Cancer Therapy
Dr. Flaherty, a national leader in the understanding of signalling pathways and the molecular biology of cancer, discusses how breakthroughs in understanding intracellular pathways will lead to personalized cancer therapy. Agents such as Sorafenib may be among the first substances that will be used in unique combinations to thwart the growth and spread of malignancies. How will these agents be developed, studied and mixed together for the optimum clinical result? How will the intense research needed for this endeavor be funded? How will the future of cancer treatment be altered?
Penn Medicine - The Ruth and Raymond Perelman Center for Advanced Medicine Video
The Promise of Proton Therapy
Dr. Stephen Hahn, professor and chair of radiation oncology at the University of Pennsylvania School of Medicine, details the basics of proton therapy and provides us with insight on how it may be used to attack cancers. Learn more about the potential of proton therapy to bring new and promising ways to reduce morbidity and side effects. Dr. Lee Freedman hosts.
The Time is Now The Place is Penn Video
The Campaign for Penn Medicine
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Explore Penn Cancer Network
